Glaukos
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.About GKOS
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.
GKOS Key Statistics
Stock Snapshot
As of today, Glaukos(GKOS) shares are valued at $112.92. The company's market cap stands at 6.49B, with a P/E ratio of -72.81.
On 2026-01-11, Glaukos(GKOS) stock traded between a low of $110.71 and a high of $114.77. Shares are currently priced at $112.92, which is +2.0% above the low and -1.6% below the high.
Glaukos(GKOS) shares are trading with a volume of 565.12K, against a daily average of 458.05K.
In the last year, Glaukos(GKOS) shares hit a 52-week high of $163.71 and a 52-week low of $73.16.
In the last year, Glaukos(GKOS) shares hit a 52-week high of $163.71 and a 52-week low of $73.16.
GKOS News
We feel now is a pretty good time to analyse Glaukos Corporation's ( ) business as it appears the company may be on the cusp of a considerable accomplishment. G...
